BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23295589)

  • 1. Differential expression of hypoxia-inducible factor 1α in non-small cell lung cancer and small cell lung cancer.
    Karetsi E; Ioannou MG; Kerenidi T; Minas M; Molyvdas PA; Gourgoulianis KI; Paraskeva E
    Clinics (Sao Paulo); 2012 Dec; 67(12):1373-8. PubMed ID: 23295589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma.
    Ioannou M; Papamichali R; Kouvaras E; Mylonis I; Vageli D; Kerenidou T; Barbanis S; Daponte A; Simos G; Gourgoulianis K; Koukoulis GK
    Lung; 2009; 187(5):321-9. PubMed ID: 19707816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
    Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
    Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
    Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
    J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
    Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
    Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.
    Berezowska S; Galván JA; Langer R; Bubendorf L; Savic S; Gugger M; Schmid RA; Marti TM
    Virchows Arch; 2017 Mar; 470(3):323-330. PubMed ID: 28062918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of hypoxia inducible factor-1 alpha and tumor cell proliferation between squamous cell carcinomas and adenocarcinomas among operable non-small cell lung carcinomas.
    Lee CH; Lee MK; Kang CD; Kim YD; Park DY; Kim JY; Sol MY; Suh KS
    J Korean Med Sci; 2003 Apr; 18(2):196-203. PubMed ID: 12692416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum tumor markers, hypoxia-inducible factor-1α HIF-1α and vascular endothelial growth factor, in patients with non- small cell lung cancer before and after intervention.
    Liang J; Qian Y; Xu D; Yin Q; Pan HJ
    Asian Pac J Cancer Prev; 2013; 14(6):3851-4. PubMed ID: 23886195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.
    Yohena T; Yoshino I; Takenaka T; Kameyama T; Ohba T; Kuniyoshi Y; Maehara Y
    J Thorac Oncol; 2009 Mar; 4(3):284-90. PubMed ID: 19190516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer.
    Furukawa T; Miyata Y; Kushitani K; Mimae T; Tsutani Y; Takeshima Y; Okada M
    Jpn J Clin Oncol; 2015 Dec; 45(12):1154-61. PubMed ID: 26386467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.
    Ping W; Jiang WY; Chen WS; Sun W; Fu XN
    Asian Pac J Cancer Prev; 2013; 14(6):3613-8. PubMed ID: 23886154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment to Posttreatment Hypoxia Inducible Factor-1α Ratios as a Potentially Predictive Marker for First-Line Treatment in Nonsmall Cell Lung Cancer Patients without Known Driver Mutations.
    Hu M; Zhang T; Gu M; Li J; Zhang H; Wang Q; Hu F; Yang Y; Li B
    Genet Test Mol Biomarkers; 2020 Dec; 24(12):798-803. PubMed ID: 33347392
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlations of 99 Tc m-HL91 SPECT hypoxia imaging with HIF-1alpha and VEGF expression in non-small cell lung cancer].
    Li L; Hu M; Yu JM; Yang GR; Guo HB; Gao Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):669-73. PubMed ID: 20021862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between HIF-1 alpha and VEGF in oral squamous cell carcinomas: Expression patterns and quantitative immunohistochemical analysis.
    Lee LT; Wong YK; Chan MY; Chang KW; Chen SC; Chang CT; Wang J
    J Chin Med Assoc; 2018 Apr; 81(4):370-375. PubMed ID: 29289482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.
    Stewart DJ; Nunez MI; Behrens C; Liu D; Lin YH; Lee JJ; Roth J; Heymach J; Swisher SG; Hong WK; Wistuba II
    J Thorac Oncol; 2014 May; 9(5):675-84. PubMed ID: 24662455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up.
    Minardi D; Lucarini G; Filosa A; Milanese G; Zizzi A; Di Primio R; Montironi R; Muzzonigro G
    Int J Immunopathol Pharmacol; 2008; 21(2):447-55. PubMed ID: 18547492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-energy dynamic CT of lung adenocarcinoma: correlation of iodine uptake with tumor gene expression.
    Yanagawa M; Morii E; Hata A; Fujiwara M; Gyobu T; Ueda K; Honda O; Tomiyama N
    Eur J Radiol; 2016 Aug; 85(8):1407-13. PubMed ID: 27423680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
    Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
    J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.